NCT07805356 · Interventional trial
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
Overall registry status Recruiting
Phase 3
Conditions Chronic Hypoparathyroidism, Hypoparathyroidism
Delaware Valley sites
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory